Hadassah

Hadassah Initiates Endoscopic Treatment for Babies' Blocked Esophagus, Replacing Risky Surgery

Tuesday, Jun 26 2012

For the first time in Israel, doctors at the Hadassah University Medical Center are employing endoscopic intervention to correct fistula (abnormal connections of the esophagus and trachea) in babies, avoiding the risky conventional surgical option.

Normally, the esophagus and the trachea are two separate, unconnected tubes. About one in every 4,000 children, however, is born with an abnormality where the esophagus is blocked at the top and at the bottom. In most cases, the esophagus is connected to the trachea. When a baby with this condition swallows, liquid can pass through the abnormal connection between the esophagus and the trachea and get into the baby's lungs and cause pneumonia.

During surgery, the abnormal connection is removed and the esophagus is reconnected at both ends. In five to ten percent of cases, however, the fistula returns, causing difficulty breathing, choking during meals, and recurrent lung infections. When this occurs, additional surgery is necessary. Each surgical intervention results in scars that can often be life threatening.

With the new treatment, the fistula is sealed by endoscopy. Prof. Chaim Springer, head of Hadassah's Pediatric Pulmonology Unit, and pediatric pulmonologists Prof. Avraham Avital and Dr. Shlomo Cohen have already performed the new procedure on eight children, successfully treating the fistula for six of them.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Thursday, Aug 15 2019

Argentinian Neurosurgeon Shares His Love for Working at Hadassah

Many years ago, neurosurgeon Andrés Vargas, born in Tucumán, Argentina, chose to live in Israel and practice medicine at Hadassah Hospital Ein Kerem.

READ MORE ›
alt_text

Wednesday, Aug 14 2019

A Hadassah Cystic Fibrosis Expert Advises the Panamanian Government

Dr. Malena Cohen, a pediatric pulmonary specialist at the Hadassah Medical Organization, traveled to Panama last week to explore the idea of opening the first cystic fibrosis (CF) center there.

READ MORE ›
alt_text

Tuesday, Aug 13 2019

Alzheimer’s Further Illuminated at Hadassah with New Exclusive Imaging Agent

The Hadassah Medical Organization, through its subsidiary SRY, has contracted to be the sole Israeli agent for General Electric to produce Vizamy, the company’s new radioactive imaging agent to detect, at an early stage, amyloid plaque, which has been linked to the development of Alzheimer’s disease.

READ MORE ›
alt_text

Friday, Aug 2 2019

New Thyroid Eye Disease Clinic at Hadassah Brings Integrated Care to New Mom

Miriam, 34, had just given birth to her third child, and, unlike the joy she felt after her first two births, she felt awful.

READ MORE ›
SUPPORT HADASSAH HOSPITALS

Learn more about the Hadassah Medical Organization.

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More